cytokine immunotherapy (Progen)

N/A

Report date: 2025/06/11 10:53:03

Base Information

Drug Namecytokine immunotherapy (Progen)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAutoimmune DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesProGen Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesProGen Co Ltd

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A